1
|
Strambo D, Michel P, Nguyen TN, Abdalkader M, Qureshi MM, Strbian D, Herweh C, Möhlenbruch MA, Räty S, Olivé-Gadea M, Ribo M, Psychogios MN, Fischer U, Nguyen A, Kuramatsu JB, Haupenthal D, Köhrmann M, Deuschl C, Kühne Escolà J, Demeestere J, Lemmens R, Vandewalle L, Yaghi S, Shu L, Puetz V, Kaiser DPO, Kaesmacher J, Mujanovic A, Marterstock DC, Engelhorn T, Requena M, Dasenbrock HH, Klein P, Haussen DC, Mohammaden MH, Abdelhamid H, Souza Viana L, Cunha B, Fragata IR, Romoli M, Diana F, Hu W, Zhang C, Virtanen P, Lauha R, Jesser J, Clark J, Matsoukas S, Fifi JT, Sheth SA, Salazar-Marioni S, Marto JP, Ramos JN, Miszczuk M, Riegler C, Poli S, Poli K, Jadhav AP, Desai SM, Maus V, Kaeder M, Siddiqui AH, Monteiro A, Masoud HE, Suryadevara N, Mokin M, Thanki S, Alpay K, Ylikotila P, Siegler JE, Linfante I, Dabus G, Asdaghi N, Saini V, Nolte CH, Siebert E, Serrallach BL, Weyland CS, Hanning U, Meyer L, Berberich A, Ringleb PA, Nogueira RG, Nagel S. Endovascular versus medical therapy in posterior cerebral artery stroke: role of baseline NIHSS and occlusion site. Stroke 2024. [PMID: 38753954 DOI: 10.1161/strokeaha.124.047383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Accepted: 05/13/2024] [Indexed: 05/18/2024]
Abstract
Background: Acute ischemic stroke (AIS) with isolated posterior cerebral artery occlusion (iPCAO) lacks management evidence from randomized trials. We aimed to evaluate whether the association between endovascular treatment (EVT) and outcomes in iPCAO-AIS is modified by initial stroke severity (baseline NIHSS) and arterial occlusion site. Methods: Based on the multicenter, retrospective, case-control study of consecutive iPCAO-AIS patients (PLATO study), we assessed the heterogeneity of EVT outcomes compared to medical management (MM) for iPCAO, according to baseline NIHSS (≤6 vs. >6) and occlusion site (P1 vs. P2), using multivariable regression modelling with interaction terms. The primary outcome was the favorable shift of 3-month mRS. Secondary outcomes included excellent outcome (mRS 0-1), functional independence (mRS 0-2), symptomatic intracranial hemorrhage (sICH) and mortality. Results: From 1344 patients assessed for eligibility, 1,059 were included (median age 74 years, 43.7% women, 41.3% had intravenous thrombolysis), 364 receiving EVT and 695 MM. Baseline stroke severity did not modify the association of EVT with 3-month mRS distribution (pint=0.312), but did with functional independence (pint=0.010), with a similar trend on excellent outcome (pint=0.069). EVT was associated with more favorable outcomes than MM in patients with baseline NIHSS>6 (mRS 0-1: 30.6% vs. 17.7%, aOR=2.01, 95%CI=1.22-3.31; mRS 0-2: 46.1% vs. 31.9%, aOR=1.64, 95%CI=1.08-2.51), but not in those with NIHSS≤6 (mRS 0-1: 43.8% vs. 46.3%, aOR=0.90, 95%CI=0.49-1.64; mRS 0-2: 65.3% vs. 74.3%, aOR=0.55, 95%CI=0.30-1.0). EVT was associated with more sICH regardless of baseline NIHSS (pint=0.467), while the mortality increase was more pronounced in patients with NIHSS≤6 (pint=0.044, NIHSS≤6: aOR=7.95,95%CI=3.11-20.28, NIHSS>6: aOR=1.98,95%CI=1.08-3.65). Arterial occlusion site did not modify the association of EVT with outcomes compared to MM. Conclusion: Baseline clinical stroke severity, rather than the occlusion site, may be an important modifier of the association between EVT and outcomes in iPCAO. Only severely affected patients with iPCAO (NIHSS>6) had more favorable disability outcomes with EVT than MM, despite increased mortality and sICH.
Collapse
Affiliation(s)
- Davide Strambo
- Stroke Centre, Neurology Service, Lausanne University Hospital, SWITZERLAND
| | - Patrik Michel
- Neurology, Center Hospitalier Universitaire Vaudois and University of Lausanne, SWITZERLAND
| | - Thanh N Nguyen
- Neurology, Radiology, Boston University Chobanian and Avedisian School of Medicine, UNITED STATES
| | - Mohamad Abdalkader
- Boston University Chobanian and Avedisian School of Medicine, UNITED STATES
| | | | - Daniel Strbian
- Neurology, Helsinki University Central Hospital, FINLAND
| | | | | | - Silja Räty
- Department of Neurology, Helsinki University Hospital and University of Helsinki, FINLAND
| | | | - Marc Ribo
- Neurology, Unitat Neurovascular, Hospital Vall d'Hebron, SPAIN
| | | | - Urs Fischer
- Department of Neurology, University Hospital Basel and University of Basel, SWITZERLAND
| | - Anh Nguyen
- Department of Neuroradiology, University Hospital Basel and University of Basel (Switzerland), SWITZERLAND
| | | | - David Haupenthal
- Department of Neurology, University of Erlangen-Nuremberg, GERMANY
| | | | - Cornelius Deuschl
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, GERMANY
| | | | | | | | | | - Shadi Yaghi
- Neurology, Alpert Medical School at Brown University, UNITED STATES
| | - Liqi Shu
- Neurology, Alpert Medical School of Brown University, UNITED STATES
| | - Volker Puetz
- Department of Neurology, Dresden University Stroke Center, University of Technology Dresden, GERMANY
| | - Daniel P O Kaiser
- Institute of Neuroradiology, University Hospital Carl Gustav Carus, GERMANY
| | - Johannes Kaesmacher
- University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern and University of Bern, SWITZERLAND
| | - Adnan Mujanovic
- Institute for Diagnostic and Interventional Neuroradiology, University Hospital Bern Inselspital and University of Bern, SWITZERLAND
| | | | | | - Manuel Requena
- Neurology. Universitat Autònoma de Barcelona, Univ Hosp Vall d'Hebron, SPAIN
| | | | - Piers Klein
- Neurology, Boston University Chobanian & Avedisian School of Medicine, UNITED STATES
| | - Diogo C Haussen
- Neurology, Neurosurgery and Radiology, Emory University School of Medicine / Grady Memorial Hospital Marcus Stroke and Neuroscience Center, UNITED STATES
| | - Mahmoud H Mohammaden
- Neurology, Emory University School of Medicine / Grady Memorial Hospital Marcus Stroke and Neuroscience Center, UNITED STATES
| | - Hend Abdelhamid
- Neurology, Emory University School of Medicine/ Grady Memorial Hospital Marcus Stroke and Neuroscience Center, UNITED STATES
| | | | - Bruno Cunha
- Centro Hospitalar Universitario de Lisboa Central, PORTUGAL
| | | | | | - Francesco Diana
- Interventional Neuroradiology, Vall d'Hebron University Hospital, SPAIN
| | - Wei Hu
- Stroke Center & Department of Neurology, the First Affiliated Hospital of USTC, CHINA
| | - Chao Zhang
- Stroke Center & Department of Neurology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, CHINA
| | - Pekka Virtanen
- Department of Radiology, Helsinki University Hospital, FINLAND
| | - Riikka Lauha
- Interventional Radiology, Helsinki University Central Hospital, FINLAND
| | | | - Judith Clark
- Boston University School of Medicine, UNITED STATES
| | - Stavros Matsoukas
- Neurosurgery, Icahn School of Medicine at Mount Sinai, UNITED STATES
| | - Johanna T Fifi
- Neurology and Neurosurgery, Icahn School of Medicine of Mount Sinai, UNITED STATES
| | - Sunil A Sheth
- Neurology, University of Texas, Houston, UNITED STATES
| | | | - João Pedro Marto
- Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, PORTUGAL
| | - João Nuno Ramos
- Neuroradiology, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, PORTUGAL
| | | | - Christoph Riegler
- Charité-Universitätsmedizin, Department of Neurology and Center for Stroke Research Berlin, GERMANY
| | - Sven Poli
- Department of Neurology & Stroke, and Hertie Institute for Clinical Brain Research, University Hospital Tuebingen, GERMANY
| | | | | | | | - Volker Maus
- Department of Radiology, Neuroradiology and Nuclear Medicine,, University Hospital Bochum, GERMANY
| | | | - Adnan H Siddiqui
- Neurosurgery, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, UNITED STATES
| | | | - Hesham E Masoud
- Neurology, Neurosurgery & Radiology, State University of New York, Upstate Medical University, UNITED STATES
| | - Neil Suryadevara
- Department of Neurology, SUNY Upstate Medical University, UNITED STATES
| | - Maxim Mokin
- Neurosurgery, University of South Florida, UNITED STATES
| | | | - Kemal Alpay
- Department of Radiology, Turku University Hospital, FINLAND
| | - Pauli Ylikotila
- Department of Cerebrovascular Disorders, Turku University Hospital, FINLAND
| | - James E Siegler
- Department of Neurology, University of Chicago, UNITED STATES
| | - Italo Linfante
- Interventional Neuroradiology, Miami Neuroscience Institute, UNITED STATES
| | - Guilherme Dabus
- Neurointerventional Surgery, Baptist Miami Neuroscience Institute, UNITED STATES
| | - Negar Asdaghi
- Medicine, University of Miami Miller School of Medicine, UNITED STATES
| | - Vasu Saini
- Interventional Neurology, Mount Sinai Medical Center, UNITED STATES
| | | | | | - Bettina L Serrallach
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Bern Inselspital, SWITZERLAND
| | | | - Uta Hanning
- Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, GERMANY
| | - Lukas Meyer
- Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg Eppendorf, GERMANY
| | | | | | | | | |
Collapse
|
2
|
Fröhlich K, Mrochen A, Wang R, Haupenthal D, Macha K, Siedler G, Knott M, Dörfler A, Schwab S, Winder K. Cerebral lesions sites in neurosarcoidosis: a lesion mapping study. J Neurol 2023; 270:5392-5397. [PMID: 37433894 PMCID: PMC10576719 DOI: 10.1007/s00415-023-11863-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 07/03/2023] [Accepted: 07/04/2023] [Indexed: 07/13/2023]
Abstract
BACKGROUND AND PURPOSE Sarcoidosis is a granulomatous disease of unknown etiology affecting the central nervous system in up to 15% of the patients. Diagnosis of neurosarcoidosis is very challenging due to the heterogeneity of its clinical manifestation. This study intended to evaluate the distribution of cerebral lesion sites and the potential presence of specific lesion clusters in neurosarcoidosis patients using voxel-based lesion symptom mapping (VLSM). METHODS Patients with neurosarcoidosis were retrospectively identified and included between 2011 and 2022. Cerebral lesion sites were correlated voxel-wise with presence and absence of neurosarcoidosis using non-parametric permutation test. Multiple sclerosis patients served as controls for the VLSM-analysis. RESULTS Thirty-four patients (mean age 52 ± 15 years) of whom 13 were diagnosed with possible, 19 with probable and 2 with confirmed neurosarcoidosis were identified. Lesion overlap of neurosarcoidosis patients demonstrated a distribution of white matter lesions in all brain areas, with a periventricular predilection similar to multiple sclerosis. In contrast to multiple sclerosis controls, no propensity for lesions in proximity of the corpus callosum was observed. Neurosarcoidosis lesions appeared smaller and lesion volume was lower in the neurosarcoidosis cohort. The VLSM analysis showed minor associations between neurosarcoidosis and damaged voxels in the bilateral frontobasal cortex. CONCLUSIONS The VLSM analysis yielded significant associations in the bilateral frontal cortex, suggesting that leptomeningeal inflammatory disease with following cortical involvement is a quite specific feature in neurosarcoidosis. Lesion load was lower in neurosarcoidosis than in multiple sclerosis. However, no specific pattern of subcortical white matter lesions in neurosarcoidosis was revealed.
Collapse
Affiliation(s)
- Kilian Fröhlich
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.
| | - Anne Mrochen
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Ruihao Wang
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - David Haupenthal
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Kosmas Macha
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Gabriela Siedler
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Michael Knott
- Department of Neuroradiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Arnd Dörfler
- Department of Neuroradiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Stefan Schwab
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Klemens Winder
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| |
Collapse
|
3
|
Haupenthal D, Schwab S, Kuramatsu JB. Hematoma expansion in intracerebral hemorrhage - the right target? Neurol Res Pract 2023; 5:36. [PMID: 37496094 PMCID: PMC10373350 DOI: 10.1186/s42466-023-00256-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Accepted: 05/30/2023] [Indexed: 07/28/2023] Open
Abstract
BACKGROUND The avoidance of hematoma expansion is the most important therapeutic goal during acute care of patients with intracerebral hemorrhage. Hematoma expansion occurs in up to 20-40% of patients and leads to poorer patient outcome in one of the most severe sub-types of stroke. MAIN TEXT At current, randomized controlled trials have failed to provide evidence for interventions that effectively improve functional outcome in patients with intracerebral hemorrhage. Hence, hematoma expansion may serve as important surrogate target that appears causally linked with a poorer prognosis. Therefore, reduction of hematoma expansion rates will eventually translate to improved patient outcome overall. Recent years have shed light on the importance of early and aggressive treatment in order to reduce the risk for hematoma expansion in these patients. Time measures and imaging markers have been identified that may allow patient selection at very high risk for hematoma expansion. CONCLUSIONS Refinements in patient selection may increase chance for randomized trials to show true benefit. Therefore, this current review article will critically evaluate and discuss available evidence associated with hematoma expansion in patients with intracerebral hemorrhage.
Collapse
Affiliation(s)
- David Haupenthal
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-University of Erlangen-Nuremberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Stefan Schwab
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-University of Erlangen-Nuremberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany
| | - Joji B Kuramatsu
- Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-University of Erlangen-Nuremberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.
| |
Collapse
|
4
|
Nguyen TN, Qureshi MM, Strambo D, Strbian D, Räty S, Herweh C, Abdalkader M, Olive-Gadea M, Ribo M, Psychogios M, Fischer U, Nguyen A, Kuramatsu JB, Haupenthal D, Köhrmann M, Deuschl C, Kühne Escola J, Yaghi S, Shu L, Puetz V, Kaiser DPO, Kaesmacher J, Mujanovic A, Marterstock DC, Engelhorn T, Klein P, Haussen DC, Mohammaden MH, Abdelhamid H, Souza Viana L, Cunha B, Fragata I, Romoli M, Diana F, Virtanen P, Lappalainen K, Clark J, Matsoukas S, Fifi JT, Sheth SA, Salazar-Marioni S, Marto JP, Ramos JN, Miszczuk M, Riegler C, Jadhav AP, Desai SM, Maus V, Kaeder M, Siddiqui AH, Monteiro A, Masoud HE, Suryadevara N, Mokin M, Thanki S, Siegler JE, Khalife J, Linfante I, Dabus G, Asdaghi N, Saini V, Nolte CH, Siebert E, Meinel TR, Finitsis S, Möhlenbruch MA, Ringleb PA, Berberich A, Nogueira RG, Hanning U, Meyer L, Michel P, Nagel S. Endovascular Versus Medical Management of Posterior Cerebral Artery Occlusion Stroke: The PLATO Study. Stroke 2023. [PMID: 37222709 DOI: 10.1161/strokeaha.123.042674] [Citation(s) in RCA: 16] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
BACKGROUND The optimal management of patients with isolated posterior cerebral artery occlusion is uncertain. We compared clinical outcomes for endovascular therapy (EVT) versus medical management (MM) in patients with isolated posterior cerebral artery occlusion. METHODS This multinational case-control study conducted at 27 sites in Europe and North America included consecutive patients with isolated posterior cerebral artery occlusion presenting within 24 hours of time last well from January 2015 to August 2022. Patients treated with EVT or MM were compared with multivariable logistic regression and inverse probability of treatment weighting. The coprimary outcomes were the 90-day modified Rankin Scale ordinal shift and ≥2-point decrease in the National Institutes of Health Stroke Scale. RESULTS Of 1023 patients, 589 (57.6%) were male with median (interquartile range) age of 74 (64-82) years. The median (interquartile range) National Institutes of Health Stroke Scale was 6 (3-10). The occlusion segments were P1 (41.2%), P2 (49.2%), and P3 (7.1%). Overall, intravenous thrombolysis was administered in 43% and EVT in 37%. There was no difference between the EVT and MM groups in the 90-day modified Rankin Scale shift (aOR, 1.13 [95% CI, 0.85-1.50]; P=0.41). There were higher odds of a decrease in the National Institutes of Health Stroke Scale by ≥2 points with EVT (aOR, 1.84 [95% CI, 1.35-2.52]; P=0.0001). Compared with MM, EVT was associated with a higher likelihood of excellent outcome (aOR, 1.50 [95% CI, 1.07-2.09]; P=0.018), complete vision recovery, and similar rates of functional independence (modified Rankin Scale score, 0-2), despite a higher rate of SICH and mortality (symptomatic intracranial hemorrhage, 6.2% versus 1.7%; P=0.0001; mortality, 10.1% versus 5.0%; P=0.002). CONCLUSIONS In patients with isolated posterior cerebral artery occlusion, EVT was associated with similar odds of disability by ordinal modified Rankin Scale, higher odds of early National Institutes of Health stroke scale improvement, and complete vision recovery compared with MM. There was a higher likelihood of excellent outcome in the EVT group despite a higher rate of symptomatic intracranial hemorrhage and mortality. Continued enrollment into ongoing distal vessel occlusion randomized trials is warranted.
Collapse
Affiliation(s)
- Thanh N Nguyen
- Neurology, Boston Medical Center, MA. (T.N.N., J.C.)
- Radiology, Boston Medical Center, MA. (T.N.N., M.M.Q., M.A., P.K.)
| | - Muhammad M Qureshi
- Radiology, Boston Medical Center, MA. (T.N.N., M.M.Q., M.A., P.K.)
- Radiation Oncology, Boston Medical Center, MA. (M.M.Q.)
| | - Davide Strambo
- Neurology Service, Lausanne University Hospital, University of Lausanne, Switzerland (D. Strambo, P.M.)
| | - Daniel Strbian
- Neurology, Helsinki University Hospital, Finland. (D. Strbian, S.R.)
| | - Silja Räty
- Neurology, Helsinki University Hospital, Finland. (D. Strbian, S.R.)
| | - Christian Herweh
- Neuroradiology, Heidelberg University Hospital, Germany. (C.H., M. Moehlenbruch)
| | | | - Marta Olive-Gadea
- Neurology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. (M.O.-G., M. Ribo)
| | - Marc Ribo
- Neurology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. (M.O.-G., M. Ribo)
| | - Marios Psychogios
- Neurology Service, Lausanne University Hospital, University of Lausanne, Switzerland (D. Strambo, P.M.)
| | - Urs Fischer
- Neurology, Basel University Hospital, University of Basel, Switzerland. (U.F.)
- Neurology, Bern University Hospital, University of Bern, Switzerland (T.R.M., U.F.)
| | - Anh Nguyen
- Radiology, Basel University Hospital, University of Basel, Switzerland. (A.N, M.P.)
| | - Joji B Kuramatsu
- Neurology, University of Erlangen-Nuremberg, Germany. (J.B.K., D.H.)
| | - David Haupenthal
- Neurology, University of Erlangen-Nuremberg, Germany. (J.B.K., D.H.)
| | - Martin Köhrmann
- Neurology, Universitätsklinikum Essen, Germany. (M. Köhrmann, J.K.E.)
| | | | | | - Shadi Yaghi
- Neurology, Rhode Island Hospital, Brown University Medical School, Providence, RI (S.Y., L.S.)
| | - Liqi Shu
- Neurology, Rhode Island Hospital, Brown University Medical School, Providence, RI (S.Y., L.S.)
| | - Volker Puetz
- Radiology, Helsinki University Hospital, Finland. (P.V., K.L.)
- Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany. (V.P.)
| | - Daniel P O Kaiser
- Neuroradiology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany. (D.P.O.K.)
| | - Johannes Kaesmacher
- Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern Inselspital, University of Bern, Switzerland (J. Kaesmacher, A. Mujanovic)
| | - Adnan Mujanovic
- Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern Inselspital, University of Bern, Switzerland (J. Kaesmacher, A. Mujanovic)
| | | | - Tobias Engelhorn
- Neuroradiology, University of Erlangen-Nuremberg, Germany. (D.C.M., T.E.)
| | - Piers Klein
- Radiology, Boston Medical Center, MA. (T.N.N., M.M.Q., M.A., P.K.)
| | - Diogo C Haussen
- Neurology, Grady Memorial Hospital, Atlanta, GA (D.C.H., M.H.M., H.A., L.S.V.)
| | | | - Hend Abdelhamid
- Neurology, Grady Memorial Hospital, Atlanta, GA (D.C.H., M.H.M., H.A., L.S.V.)
| | - Lorena Souza Viana
- Neurology, Grady Memorial Hospital, Atlanta, GA (D.C.H., M.H.M., H.A., L.S.V.)
| | - Bruno Cunha
- Neuroradiology, Centro Hospitalar Universitario de Lisboa Central, Portugal (B.C., I.F.)
| | - Isabel Fragata
- Neuroradiology, Centro Hospitalar Universitario de Lisboa Central, Portugal (B.C., I.F.)
| | - Michele Romoli
- Neurology and Stroke Unit, Department of Neuroscience, Bufalini Hospital, Cesena, Italy (M. Romoli)
| | - Francesco Diana
- Interventional Neuroradiology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. (F.D.)
| | - Pekka Virtanen
- Radiology, Helsinki University Hospital, University of Helsinki, Finland (P.V., K.L.)
| | - Kimmo Lappalainen
- Radiology, Helsinki University Hospital, Finland. (P.V., K.L.)
- Radiology, Helsinki University Hospital, University of Helsinki, Finland (P.V., K.L.)
| | - Judith Clark
- Neurology, Boston Medical Center, MA. (T.N.N., J.C.)
| | - Stavros Matsoukas
- Neurosurgery, Mount Sinai Health System, New York City, NY (S.M., J.T.F.)
| | - Johanna T Fifi
- Neurosurgery, Mount Sinai Health System, New York City, NY (S.M., J.T.F.)
| | - Sunil A Sheth
- Neurology, McGovern Medical School at UTHealth, TX (S.A.S., S.S.-M.)
| | | | - João Pedro Marto
- Neurology, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Portugal. (J.P.M.)
| | - João Nuno Ramos
- Neuroradiology, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Portugal. (J.N.R.)
| | - Milena Miszczuk
- Neuroradiology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Germany. (M. Miszczuk, E.S.)
| | - Christoph Riegler
- Neurology, Experimental Neurology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Germany. (C.R., C.H.N.)
| | - Ashutosh P Jadhav
- Neurosurgery, Barrow Neurological Institute, Phoenix, AZ (A.P.J., S.M.D.)
| | - Shashvat M Desai
- Neurosurgery, Barrow Neurological Institute, Phoenix, AZ (A.P.J., S.M.D.)
| | - Volker Maus
- Radiology, Neuroradiology and Nuclear Medicine, University Hospital Knappschaftskrankenhaus Bochum, Germany (V.M., M. Kaeder)
| | - Maximilian Kaeder
- Radiology, Neuroradiology and Nuclear Medicine, University Hospital Knappschaftskrankenhaus Bochum, Germany (V.M., M. Kaeder)
| | | | - Andre Monteiro
- Neurosurgery, University of Buffalo, NY (A.H.S., A. Monteiro)
| | - Hesham E Masoud
- Neurology, New York Upstate Medical University, Syracuse, NY (H.E.M.)
| | | | - Maxim Mokin
- Neurosurgery, University of South Florida, Tampa (M. Mokin, S.T.)
| | - Shail Thanki
- Neurosurgery, University of South Florida, Tampa (M. Mokin, S.T.)
| | - James E Siegler
- Cooper Neurological Institute, Camden, NJ (J.E.S., J. Khalife)
| | - Jane Khalife
- Cooper Neurological Institute, Camden, NJ (J.E.S., J. Khalife)
| | | | | | - Negar Asdaghi
- Neurology, University of Miami Miller School of Medicine, FL (N.A., V.S.)
| | - Vasu Saini
- Neurology, University of Miami Miller School of Medicine, FL (N.A., V.S.)
| | - Christian H Nolte
- Neurology, Experimental Neurology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Germany. (C.R., C.H.N.)
| | - Eberhard Siebert
- Neuroradiology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Germany. (M. Miszczuk, E.S.)
| | - Thomas R Meinel
- Neurology, Bern University Hospital, University of Bern, Switzerland (T.R.M., U.F.)
| | | | - Markus A Möhlenbruch
- Neuroradiology, Heidelberg University Hospital, Germany. (C.H., M. Moehlenbruch)
| | - Peter A Ringleb
- Neurology, Heidelberg University Hospital, Germany. (P.A.R., S.N.)
| | | | - Raul G Nogueira
- Neurology, University of Pittsburgh Medical Center, PA (R.G.N., N.S.)
| | - Uta Hanning
- Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (U.H., L.M.)
| | - Lukas Meyer
- Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (U.H., L.M.)
| | - Patrik Michel
- Radiology, Basel University Hospital, University of Basel, Switzerland. (A.N, M.P.)
| | - Simon Nagel
- Neurology, Heidelberg University Hospital, Germany. (P.A.R., S.N.)
- Neurology, University of Pittsburgh Medical Center, PA (R.G.N., N.S.)
| |
Collapse
|
5
|
Winder K, Bobinger T, Seifert F, Mrochen A, Haupenthal D, Knott M, Dörfler A, Hilz MJ, Schwab S, Fröhlich K. Incidence, temporal profile and neuroanatomic correlates of poststroke epilepsy. J Neuroimaging 2023. [PMID: 37129978 DOI: 10.1111/jon.13110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Revised: 04/11/2023] [Accepted: 04/21/2023] [Indexed: 05/03/2023] Open
Abstract
BACKGROUND AND PURPOSE The relationship between ischemic stroke site and occurrence of poststroke epilepsy (PSE) is incompletely understood. This study intended to evaluate incidence and temporal profiles of seizures and to correlate ischemic lesion sites with PSE using voxel-based lesion symptom mapping (VLSM). METHODS Patients with imaging-confirmed first-ever ischemic stroke without prior history of epilepsy were prospectively included. Demographic data, cardiovascular risk factors, and National Institute of Health Stroke Scale (NIHSS) scores were assessed. Data on seizures and modified Rankin scale scores were determined within a 90-day period after stroke onset. Ischemic lesion sites were correlated voxel wise with occurrence of PSE using nonparametric permutation test. Age- and sex-matched patients with first-ever ischemic strokes without PSE after 90 days served as controls for the VLSM analysis. RESULTS The stroke database contained 809 patients (mean age: 68.4 ± 14.2 years) with first-ever imaging-confirmed ischemic strokes without history of epilep. Incidence of PSE after 90-day follow-up was 2.8%. Five additional patients were admitted to the emergency department with a seizure after 90-day follow-up. Fifty percent of the seizures occurred in the acute phase after stroke. PSE patients had higher NIHSS scores and infarct volumes compared to controls without PSE (p < .05). PSE patients had infarcts predominantly involving the cerebral cortex. The hemisphere-specific VLSM analysis shows associations between PSE and damaged voxels in the left-hemispheric temporo-occipital transition zone. CONCLUSIONS The data indicate that PSE occurs in a small proportion of patients with rather large ischemic strokes predominantly involving the cerebral cortex. Especially patients with ischemic lesions in the temporo-occipital cortex are vulnerable to develop PSE.
Collapse
Affiliation(s)
- Klemens Winder
- Department of Neurology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
- Department of Neurology and Stroke Center, Klinik Hirslanden, Zürich, Switzerland
| | - Tobias Bobinger
- Department of Neurology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Frank Seifert
- Department of Neurology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Anne Mrochen
- Department of Neurology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - David Haupenthal
- Department of Neurology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Michael Knott
- Department of Neuroradiology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Arnd Dörfler
- Department of Neuroradiology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Max J Hilz
- Department of Neurology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Stefan Schwab
- Department of Neurology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Kilian Fröhlich
- Department of Neurology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| |
Collapse
|
6
|
Wang R, Macha K, Haupenthal D, Gaßmann L, Siedler G, Stoll S, Fröhlich K, Koehn J, Schwab S, Kallmünzer B. Acute care and secondary prevention of stroke with newly detected versus known atrial fibrillation. Eur J Neurol 2022; 29:1963-1971. [PMID: 35344638 DOI: 10.1111/ene.15338] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2022] [Accepted: 03/25/2022] [Indexed: 11/30/2022]
Abstract
BACKGROUND Atrial fibrillation (AF) in stroke patients can be classified as either "known AF (KAF)", which was confirmed before stroke-onset, or "AF detected after stroke (AFDAS)", which was diagnosed after stroke-onset. While KAF is considered primarily cardiogenic, AFDAS includes patients with stroke-triggered neurogenic arrhythmias. This study aimed to investigate the clinical course of stroke, functional outcome and the value of oral anticoagulation for secondary prevention according to AF subtype. METHODS Acute ischemic stroke patients were consecutively enrolled, AF was classified as AFDAS or KAF. Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) and the three-month functional outcome was measured on the modified Rankin scale. Inverse probability weighting was applied to adjust baseline confounders in patients with AFDAS and KAF. Multivariate logistic regression models were calculated to investigate the value of oral anticoagulation for secondary prevention. RESULTS 822 stroke patients with AF were included, 234 patients (28.5%) had AFDAS. AFDAS patients had lower prevalence of coronary artery disease, heart failure, and sustained AF, but higher rates of large-vessel occlusion compared to KAF patients. NIHSS-scores were lower in patients on pre-stroke anticoagulation. Oral anticoagulation for secondary prevention was associated with a favorable three-month functional outcome (odds ratio 7.60, 95% confidence interval 3.42-16.88) independently from AF subtype. The rate of stroke recurrence did not differ significantly. CONCLUSIONS Clinical characteristics suggest that AFDAS might comprise a distinct pathophysiologic and clinical entity among stroke patients with AF. The benefit of anticoagulation for secondary prevention was not affected by AF subtype.
Collapse
Affiliation(s)
- Ruihao Wang
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Kosmas Macha
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - David Haupenthal
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Luise Gaßmann
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Gabriela Siedler
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Svenja Stoll
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Kilian Fröhlich
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Julia Koehn
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Stefan Schwab
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Bernd Kallmünzer
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| |
Collapse
|
7
|
Haupenthal D, Kuramatsu JB, Volbers B, Sembill JA, Mrochen A, Balk S, Hoelter P, Lücking H, Engelhorn T, Dörfler A, Schwab S, Huttner HB, Sprügel MI. Disability-Adjusted Life-Years Associated With Intracerebral Hemorrhage and Secondary Injury. JAMA Netw Open 2021; 4:e2115859. [PMID: 34279649 PMCID: PMC8290300 DOI: 10.1001/jamanetworkopen.2021.15859] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
IMPORTANCE Intracerebral hemorrhage (ICH) contributes significantly to the global burden of disease. OBJECTIVE To examine the association of ICH and secondary injury with disability-adjusted life-years (DALYs) for the individual patient. DESIGN, SETTING, AND PARTICIPANTS This cohort study was conducted using data from the Universitätsklinikum Erlangen Cohort of Patients With Spontaneous Intracerebral Hemorrhage study. Consecutive patients admitted to a single tertiary care center from January 1, 2006, to December 31, 2015, were included. The sample comprised patients with oral anticoagulation-associated ICH (OAC-ICH) or primary spontaneous ICH (non-OAC-ICH). Statistical analysis was conducted from October 1 to December 31, 2020. EXPOSURES ICH occurrence and secondary injury. MAIN OUTCOMES AND MEASURES DALYs, years of life lost (YLL), and years lived with disability (YLD) were analyzed by hematoma location, ICH volume, and secondary injury (ie, hematoma expansion [HE], intraventricular hemorrhage [IVH], and perihemorrhagic edema [PHE]). RESULTS Among 1322 patients with ICH, 615 (46.5%) were women and the mean (SD) age at hospital admission was 71 (13) years; ICH was associated with a mean (SD) of 9.46 (8.08) DALYs, 5.72 (8.29) YLL, and 3.74 (5.95) YLD. There were statistically significant differences in mean (SD) DALYs by extent of hematoma volume (< 10 mL ICH: 7.05 [6.79] DALYs; 10-30 mL ICH: 9.91 [8.35] DALYs; >30 mL ICH: 12.42 [8.47] DALYs; P < .001) and ICH location (deep location: 10.60 [8.35] DALYs; lobar location: 8.18 [7.63] DALYs; cerebellum: 8.14 [6.80] DALYs; brainstem: 12.63 [9.21] DALYs; P < .001). Regarding population-level disease burden of secondary injuries after ICH, there was a statistically significant difference in mean (SD) by injury type, with 0.94 (3.19) DALYs for HE, 2.45 (4.16) DALYs for IVH, and 1.96 (2.66) DALYs for PHE (P < .001) among the entire ICH cohort. Regarding individual-level exposure to secondary injuries after ICH, there were a mean (SD) 7.14 (6.62) DALYs for HE, 4.58 (4.75) DALYs for IVH, and 3.35 (3.28) DALYs for PHE among patients with ICH affected by secondary injuries. CONCLUSIONS AND RELEVANCE These findings suggest that there is a high burden of disability associated with ICH and secondary injuries, and the findings may guide public health strategies. The study findings further suggest that IVH and PHE may be relevant for the overall outcome of patients with ICH, that DALYs may represent a viable outcome parameter for studies to evaluate treatment outcomes in ICH research, and that IVH and PHE may represent potential treatment targets.
Collapse
Affiliation(s)
- David Haupenthal
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Joji B. Kuramatsu
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Bastian Volbers
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Jochen A. Sembill
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Anne Mrochen
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Stefanie Balk
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Philip Hoelter
- Department of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Hannes Lücking
- Department of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Tobias Engelhorn
- Department of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Arnd Dörfler
- Department of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Stefan Schwab
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Hagen B. Huttner
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Maximilian I. Sprügel
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| |
Collapse
|